Atwood & Palmer’s Dentsply Sirona XRAY Stock Holding History

Atwood & Palmer’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-363	Closed	-$18K	–	459
2022 Q1	$18K	Hold	363	–	–	﹤0.01%	328
2021 Q4	$20K	Hold	363	–	–	﹤0.01%	319
2021 Q3	$21K	Hold	363	–	–	﹤0.01%	301
2021 Q2	$23K	Hold	363	–	–	﹤0.01%	283
2021 Q1	$23K	Buy	+363	New	+$21.1K	﹤0.01%	284

Other funds holding XRAY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Atwood & Palmer's XRAY Position: Q2 2022 in Review

Atwood & Palmer sold out of Dentsply Sirona (XRAY) in Q2 2022, closing a stake of 363 shares — an estimated $18K sold.

Atwood & Palmer first reported a position in XRAY in Q1 2021 and held it in 5 quarters. The position peaked at $23K in Q2 2021. 470 funds tracked by Wall St. Rank hold XRAY as of Q2 2022.

Atwood & Palmer reported no remaining Dentsply Sirona position as of Q2 2022 after selling out during the quarter.
Atwood & Palmer sold 363 Dentsply Sirona shares in Q2 2022, an estimated $18K.
Atwood & Palmer first reported a position in Dentsply Sirona in Q1 2021 and held it in 5 quarters.
Atwood & Palmer's Dentsply Sirona position peaked at $23K in Q2 2021.
470 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2022.

Based on Atwood & Palmer's 13F filing for Q2 2022, filed 21 Jul 2022.